| Primary information |
|---|
| ID | 11232 |
| Uniprot ID | O42143 |
| Description | Glucagon-1 precursor (Glucagon I) [Cleaved into- - Glucagon; Glucagon-likepeptide 1A (GLP-1A); Glucagon-like peptide 1B (GLP-1B); Glucagon-likepeptide 1C (GLP-1C); Glucagon-like peptide 2 (GLP-2)]. |
| Organism | Xenopus laevis |
| Txonomy | Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;Amphibia; Batrachia; Anura; Mesobatrachia; Pipoidea; Pipidae;Xenopodinae; Xenopus; Xenopus. |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | Belongs to the glucagon family. |
| Tissue Specificity | NA |
| Post Translational Modification | NA |
| Function | Promotes hydrolysis of glycogen and lipids; and raises the blood sugar level |
| Length | 266 |
| Molecular Weight | 30951 |
| Name | Glucagon-like peptide 2 |
| Sequence | HADGSFTNDINKVLDIIAAQEFLDWVINTQETE |
| Sequence map | 33 (227-259) |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | Q8UVY5 |
| Domain | NA |
| Pharmaceutical Use | NA
|